Defining Effective Migraine Performance Measures

Actually, migraine is a chronic condition affecting 15% of the U.S. population. Specifically, the development of robust migraine performance measures is essential for improving clinical outcomes. Therefore, the American College of Physicians (ACP) recently conducted a rigorous review of current standards. Furthermore, the Performance Measurement Committee published their findings in the Annals of Internal Medicine. Consequently, the report highlights the need for evidence-based and methodologically sound tools. Notably, only one measure is currently utilized in pay-for-performance programs. However, the ACP found this tool focuses on a minimal performance gap. Moreover, the measure relies on outdated clinical guidance. Thus, the committee does not recommend its broad adoption. Instead, they urge for more reliable metrics to reduce the reporting burden on physicians.

Challenges in Standardizing Migraine Performance Measures

In addition, the committee explored potential concepts for future migraine performance measures. Specifically, they reviewed clinical guidelines for preventing episodic migraine and treating acute attacks. Nonetheless, many of these recommendations rely on low-certainty evidence. For instance, documenting the use of over-the-counter treatments remains a feasibility challenge. Consequently, the committee decided against proposing a new core measure concept at this time. Furthermore, they emphasized that high-quality measures must be valid and reliable. Because of this, developers must continue to refine and test these tools. Similarly, clinicians should focus on personalized, evidence-based care plans. Notably, the goal remains to improve patient care without increasing administrative tasks. Finally, the ACP continues to support measurement that meets high methodological standards.

Frequently Asked Questions

What are the current migraine performance measures?

Currently, the primary measure in use focuses on reducing the overuse of imaging for primary headaches. However, the ACP recently found this measure to be insufficient for improving overall care quality.

Why did the ACP reject the existing core measure?

The ACP rejected the measure because it lacked appropriate testing and relied on outdated guidelines. Moreover, the measure added an unnecessary reporting burden for individual physicians without offering significant clinical benefits.

How should clinicians approach migraine care in the absence of core measures?

Clinicians should continue to follow the latest evidence-based guidelines for migraine prevention and treatment. Specifically, focus on personalized therapy and documented patient outcomes while developers work on more valid performance metrics.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Qaseem A et al. Core Performance Measures for Migraine Headache: A Review by the American College of Physicians. Ann Intern Med. 2026 Apr 21. doi: 10.7326/ANNALS-25-04726. PMID: 42008806.

American Headache Society. The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache. 2019;59(1):1-18.

Goadsby PJ, et al. Migraine — Current Understanding and Treatment. N Engl J Med. 2017;377(6):553-561.